BridgeMD
New treatment option for Ankylosing Spondylitis
Official title Clinical Trial Study on the Improved New Method of Acupotomy for AS
ClinicalTrials.gov ID: NCT07578220
What this study is testing
- What it's testing
- This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Meeting the 1984 revised New York criteria or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial...
- Age 18-75 years
- BASDAI ≥4
- Signed informed consent form
You likely can't join if
- Presence of autoimmune diseases other than the studied condition
- Complete spinal ankylosis or spinal deformity
- Pregnant or lactating women
- Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, malignant tumors, or coagulation disorders
- Patients unable to comply with data collection due to mental, linguistic, or similar factors
- Patients with psoriatic arthritis, reactive arthritis, or inflammatory bowel disease-associated spondyloarthritis
The study team makes the final eligibility decision.
Where it's taking place
- Henan, Zhengzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Henan, Zhengzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.